The District of Delaware's chief judge recently held in two rulings that companies must have permanent ties to the state to face patent suits there following the U.S. Supreme Court's TC Heartland ruling, and his analysis could keep many generic-drug cases in his court. Here's what attorneys can learn from the decisions.
Deposition Sciences Inc. has sued Reed Smith over what the company claims is a botched patent filing.
Drug maker GlaxoSmithKline PLC and generic pharmaceutical company Eon Labs Inc. have settled all patent litigation regarding Eon's Bupropion HCl, ER 100 mg and 10 mg tablets, the two companies said.
Drug maker Bristol-Myers Squibb and Israeli generic drug maker Teva Pharmaceutic Industries have settled patent litigation related to carboplatin injection, the generic version of cancer treatment Paraplatin.
The Supreme Court has refused to consider a trademark dispute over Idaho russet potatoes.
A Massachusetts software company has sued Oracle Corp., the world’s third largest software maker, in Texas district court for patent infringement related to a method of increasing data-processing speed.
In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has rejected a key claim for the U.S. patent covering Paxil, the world’s top-selling antidepressant.
Israel’s government, under intense pressure from the country’s generic drug industry, has postponed proposed amendments to the patent law demanded by U.S. officials.
French insurance company AXA has sued Google Inc. in the latest trademark challenge to the popular search engine’s controversial advertising model.
A U.S. District Court judge has upheld a decision favoring Atrium Medical Corp. in a patent lawsuit brought by Genzyme Corp.
A Texas-based software maker has sued 31 major hardware and software vendors, including Dell and Apple Computer, for allegedly infringing on its claim to an algorithm used in the popular JPEG picture file format.
A U.S. District Court judge has dismissed MedImmune's patent lawsuit against biotech company Genentech over technology to create drugs using antibody molecules.
The U.S. Justice Department’s new Intellectual Property Task Force will consist of panel members from throughout the executive branch, including the department’s antitrust division, the Federal Bureau of Investigation and the Homeland Security Department, according to chairman David M. Israelite.
A U.S. District Court Judge in Kentucky has ordered Barton Brands Ltd. to change the name of its Ridgewood Reserve 1792 bourbon, handing a victory to Brown-Forman Corp. in its trademark lawsuit against the rival liquor producer.
The University of Akron School of Law will launch a Master of Law (LL.M.) degree program in intellectual property in the fall of 2004, creating the 17th such program in the U.S.
Patriot Scientific Corp., a small technology company in Southern California, has expanded its litigation against top players in the computer industry over semiconductor clock speeds.
A shoe company has filed a lawsuit in the U.S. District Court for the District of Massachusetts against a designer it says infringed on its trademarks and engaged in unfair trade practices.
South Korea has formally protested Japan’s ban on imports of Samsung SDI's plasma display panel screens, as patent litigation between Samsung and Fujitsu threatens to escalate to a trade dispute between the two countries.
A German parliamentary group has postponed the completion of a list of patent-protected drugs for which public health insurers will pay fixed prices.
The U.S. Court of Appeals for the Federal Circuit will hear the appeal in the closely observed dispute between Research in Motion and NTP over the patents covering Blackberry devices on June 7.
The merger between Hale and Dorr and Wilmer Cutler Pickering will bring together two intellectual property practices with little overlap and no significant conflicts of interests.